Stay updated on Daratumumab for AML/High-Risk MDS Clinical Trial

Sign up to get notified when there's something new on the Daratumumab for AML/High-Risk MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab for AML/High-Risk MDS Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page. No changes to study data or page navigation are indicated.
    Difference
    0.1%
    Check dated 2026-03-11T23:27:47.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the notice about lapse in government funding and the previous Revision: v3.4.1 entry.
    Difference
    0.5%
    Check dated 2026-02-11T10:28:30.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a page revision indicator (v3.4.1). Removed the previous revision indicator (v3.4.0).
    Difference
    0.5%
    Check dated 2026-02-04T06:23:02.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Show glossary was added and labels related to QC updates and No FEAR Act data were adjusted, with the revision tag updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:24:11.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision note updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:10:40.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Locations section added, listing Texas (MD Anderson Cancer Center) as a site. The Texas Locations heading and the HHS Vulnerability Disclosure link were removed.
    Difference
    0.2%
    Check dated 2025-12-23T08:44:51.000Z thumbnail image

Stay in the know with updates to Daratumumab for AML/High-Risk MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab for AML/High-Risk MDS Clinical Trial page.